Baric Transcribed Interview (Redacted) — page 137

DC.Scheduling@LexitasLegal.com are really good and the spike is really good. Polymerase has gaps in it. We can't close those gaps based on their sequence, using all kinds of different program to try to do it. Now, they may have an in-house program that they used, but personally I think they used a reference sequence and they guessed, to fill the gaps. That's my gut feeling. MS. SALAZAR: And I had asked you if you had ever not published something. So that's part of what happened in this case. I understand it was partially uploaded and then it was under embargo. So have you ever had a sequence or something under embargo that then you withdrew? I just want to make sure that my initial question of you didn't publish anything is complete, because I understand that you can submit something. DR. BARIC: You can pull it off, yeah. I don't believe we have ever, no. I mean, why would we? We were using public sequences to build viruses. It's not like we were doing this de novo. MS. SALAZAR: Okay. DR. BARIC: Just to let you know, we have ordered a molecular clone for RaTG13. That genome is heavily debilitated. We eventually isolated it. We have not finished submitting the paper. MS. SALAZAR: Okay. And when did you isolate it?